Miami Cancer Institute
Professor Mehta is a world-renowned expert in radiation oncology, proton therapy and cancer research. He is Deputy Director and Chief of Radiation Oncology of Miami Cancer Institute at Baptist Health South Florida since November 2015 and oversees South Florida’s first and only Proton Therapy Center. . He was Medical Director.previously at Baptist University Maryland’s Proton Treatment Center, where he launched mid-Atlantic’s first dedicated pencil-beam proton treatment center. He was associate director of clinical research at the University of Maryland School of Medicine’s Department of Radiation Oncology. Previously, he was the chairman of the University of Wisconsin School of Medicine and Public Health’s Department of Human Oncology, where he led numerous research studies, innovative technology innovation and implementation (Tomotherapy), and substantial practice expansion of the University of Wisconsin Cancer Center Clinical operations. He was also program leader for the University of Wisconsin’s Comprehensive Cancer Center’s Imaging and Radiation Sciences Program for under 15 years, led a program project grant in radiation oncology, and has been the chair of the RTOG/NRG oncology’s brain tumor committee for over 15 years. Dr. Mehta has designed and led several national and international clinical studies, receiving NIH and NCI grants and been awarded many honors. He has held national leadership positions in numerous organizations including the American Board of Radiology, the FDA Radiological Devices Panel, the American Society for Radiation Oncology, the American Society of Clinical Oncology, the Society of Neuro-Oncology, etc. A well-respected clinician and researcher, Dr. Mehta has over a thousand publications, including medical journal manuscripts, book chapters, and professional abstracts, and serves on the editorial board of several peer-reviewed journals. Dr. Mehta graduated from the University of Zambia School of Medicine and completed his residency at the University of Wisconsin, where he was chief resident in radiation oncology.